Summary. Sheep placentomes were collected at the abattoir and the stage of gestation was estimated from the crown\p=n-\rumplength and appearance of the fetus. Samples were extracted and either freeze dried (crude extracts) or fractionated on Sephadex G-50 and CM-cellulose. Relaxin immunoreactivity (RXN-IR) was detected in all samples by a pig relaxin RIA and diluted in parallel with the standard curve. Two patterns of RXN\x=req-\ IR were seen after Sephadex G50 purification: (a) a single main peak of RXN-IR eluting at a position similar to pig relaxin; or (b) a 3-peak pattern with additional higher (void volume) and lower (\m=~\1000) molecular weight peaks. These peaks were all found with 4 different and specific antisera. The 6000 molecular weight peak eluted at a similar position to pig relaxin on CM cellulose and inhibited electrically stimulated rat uterine contractions in vitro. The amount of relaxin measured in crude extracts of placentomes from different ewes was very variable. Most samples were within the range 0\m=.\05\p=n-\11\m=.\2 ng/g wet weight of tissue (3\m=.\0\ m=+-\ 0\m=.\45 (s.e.m.), n = 44) but a few contained much higher concentrations (25\ m=. \ 5\ p=n-\ 61\ m=. \ 4ng/g, n = 3). There was no obvious variation in concentration with stage of pregnancy (20 days to term). Samples of intercotyledonary endometrium, allantochorion and whole ovaries from pregnant ewes were also extracted. All contained low concentrations of RXN-IR (0\m=.\6\ m=+-\0\m=.\13ng/g, n = 4; 0\ m=. \ 6 \m=+-\0\ m=. \ 29 ng/g, n = 3; 1\m=.\0 \ m=+-\ 0\m=.\66 ng/g, n = 7, respectively). We conclude that relaxinlike peptides are present in the pregnant ewe and that, as the placentomes are the largest component by weight, they represent the major source.
Introduction
Relaxin is a peptide hormone with a molecular weight of about 6000 consisting of two chains linked by disulphide bonds. Amino acid sequence analysis has been performed on relaxin obtained from ovarian extracts of pregnant pigs, rats and sharks and this has shown that there is only limited sequence homology among species (for reviews see Bryant-Greenwood, 1982 ; Sherwood & Downing, 1983) . Ideally, studies on the biological actions of relaxin in other species should therefore be based on homologous preparations. Relaxin-like activity has been identified in a variety of mammals by both immuno-and bioactivity. Immunological studies have generally been based on pig relaxin standards and antisera. Sites of localization of relaxin appear to vary among species and include both the ovary and placenta in the human (O'Byrne et al, 1978; Bigazzi et al, 1982) , the endometrial glands in the guinea-pig (Pardo & Larkin, 1982) and the syncytiotrophoblast in the rabbit (Eldridge & Fields, 1985) .
Relaxin is of potential clinical importance in ruminants, both to ease labour and to dilate the cervix to facilitate artificial insemination and embryo transfer. Fields et al (1980) have provided substantial evidence that relaxin is present in corpora lutea collected from late pregnant cows, but work on the ewe has been limited. Several studies based on the first relaxin radioimmunoassay which used a relatively impure preparation of pig relaxin suggested that significant quantities of relaxin were present in plasma collected from ewes during the oestrous cycle (Chamley et al, 1975) , pregnancy (Bryant & Chamley, 1976a) and lactation (Bryant & Chamley, 1976b) . More recently Renegar & Larkin (1985) measured only low levels of relaxin immunoreactivity in the endometrium, placenta, ovary and blood of pregnant ewes, and were unable to demonstrate biological activity.
In this study we report the results of a series of experiments in which we have attempted to isolate and characterize relaxin in sheep.
Materials and Methods
Collection of tissue. Tissue samples were obtained from the abattoir and frozen within 15 min of death on solid C02 or in liquid nitrogen. From non-pregnant ewes whole uteri were collected, and from pregnant ewes whole ovaries, whole placentomes, intercotyledonary endometrium and allantochorion were obtained. The stage of pregnancy was esti¬ mated from the crown-rump length and external appearance of the fetus (Evans & Sack, 1973 Chromatography. Initial purification was performed using a column of Sephadex G-50 (fine, 90 1-6 cm) equili¬ brated in 01 M-ammonium acetate buffer pH 50 and run using upward flow at a rate of about 10 ml h-1 at 4°C. Fractions (7-5 ml) were collected, lyophilized, split into several aliquants for analysis, lyophilized again and stored Peaks of immunoreactive relaxin-like material from several extractions were pooled and purified further by ion-exchange chromatography using a 6 0-8 cm column of CM52 carboxymethyl cellulose (Whatman, Chester, U.K.) equilibrated with 005 M-ammonium acetate buffer pH 50 at 4"C. Unabsorbed protein was eluted with 005 Mammonium acetate buffer and then a linear gradient was applied by mixing 005 and 0-5 M-ammonium acetate buffer with a gradient mixer (Pharmacia Fine Chemicals, Uppsala, Sweden). Initially, 1-ml fractions were collected. These were either pooled in peaks according to the protein profile (monitored by absorbance at 280 nm) or, if no clear peak pattern emerged, they were pooled in batches of 10. The conductivity was measured and the pooled fractions were lyophilized as described above.
Radioimmunoassay. Freeze-dried extracts were reconstituted in 1 ml 005 M-sodium barbitone buffer pH 8-5 containing 1% bovine serum albumin (BSA) and were measured in triplicate at 2-3 dilutions in a modified version of the radioimmunoassay based on pig relaxin as described previously (Taverne et a!, 1982; Evans et ai, 1983) . NIH-RXN-P1 was used as the standard and CM purified relaxin (2000-3000 guinea-pig units/mg) was used for iodination. The antiserum P7AsRb used for most of the study was raised in a rabbit against an extract of pig relaxin purified on Sephadex G50 and cross-reacted <002% with pig prolactin and <01% with pig insulin. The use of this antiserum was corroborated by comparison with the radioimmunoassay results obtained using three additional antisera, (i) Antiserum PM AB4 was raised at Bristol using a similar source of antigen and then purified by affinity chromatography. Purified CMa relaxin (200 pg) was coupled to 310 mg CNBr-activated Sepharose (Pharmacia Fine Chemicals, Uppsala, Sweden) and the resultant relaxin-Sepharose beads were mixed with 0-4 ml PMAB4 antiserum in 5 ml 005 Mbarbitone buffer pH 8-5 overnight at 4°C. After removal of the supernatant, the beads were washed and bound antibodies to CMa relaxin were removed using 5 ml 50% (v/v) ethylene glycol in 0-5 M-acetic acid. The antibody solution was dialysed against 01 M-Tris-HCl pH 7-6 using a CX-30 ultrafiltration unit (Millipore, Bedford, MA, U.S.A.) and stored at -20°C. (ii) Antiserum R6 was also raised against a G-50 fraction, 1000 U/mg (O'Byrne & Steinetz, 1976) and (iii) Antiserum 1082 was raised against a combination of CM-B, CM-a and CM-a' (Sherwood et ai, 1975) . The sensitivity of the main assay was 16pg per tube and the intra-and inter-assay coefficients of variation were 8-4 and 13-8%. All values are given as ng equivalents of the NIH-RXN-P1 pig relaxin standard and are referred to as relaxin immunoreactivity (RXN-IR).
Bioassay. Freeze-dried extracts were redissolved in 0-5 ml Krebs-Henseleit buffer and added to an organ bath containing an electrically stimulated uterine strip taken from a pro-oestrous rat. The details of the methodology have been described previously (Bradshaw et ai, 1981) . The amplitudes of the 10 contractions immediately before and 10 immediately after the addition of extract were measured and the results are expressed as the mean percentage change in the amplitude of the contractions between these two time periods. The minimum amount of pig relaxin which has a reproducible effect in this system varies from 50 to 500 ng depending on different uterine strips and batches of relaxin. BSA, at concentrations of up to 2 mg protein per bath, had no effect whereas higher concentrations of BSA tended to stimulate contractions. 
Results

Placentomes
Immunoreactivity. Initial studies suggested that placentomes collected during mid-pregnancy contained more relaxin-like material than did corpora lutea, and so these were used as the starting point for most of the work. Several cotyledons (usually 3) from each sheep were extracted and purified on Sephadex G-50 as described above and each fraction was measured by relaxin RIA. This procedure was performed on 19 occasions.
There was considerable variation among extractions but some RXN-IR was measured on all but one occasion, with two elution patterns predominating ( Fig. 1 ). In one there was a single main peak of immunoreactivity which eluted in the region of Mt 6000, whereas in the other there were 3 clear peaks of activity which were termed the high, mid-and low molecular weight peaks. The high peak eluted in the void volume, indicating a molecular weight in excess of 20 000 whereas the low peak ran in a position similar to oxytocin, suggesting an apparent molecular weight of about 1000. Elution volume (ml) (Fig. 3) . This RXN-IR, as well as that in crude extracts, diluted in parallel with the pig relaxin standard curve (Fig. 4) Table 3 ).
The RXN-IR measurements in crude extracts of single placentomes from 44 ewes at all stages of pregnancy are shown in Table 2 and are compared with the concentrations found in non-gravid whole uterus from ewes in the luteal phase. Whilst the amounts present were clearly higher in the placentomes, there was no obvious trend throughout pregnancy and there was considerable variation among animals (placentomes) at each stage.
The relaxin concentrations in these individual crude extracts were compared with those measured in the material purified on Sephadex G-50. For the 8 Sephadex G-50 runs for which the stage of pregnancy was known, the immunoreactivity in each fraction was summed and divided by the weight of starting material. The overall relaxin concentrations in ng/g were in the same range as that found in the unpurified material (1-6 ± 0-5 ng/g (mean ± s.e.m. (Fig. 5) . For the G-50 fractions a clear region of inhibitory activity was associated with the mid-molecular weight peak in 3 experiments (see Table 3 ) and the low molecular weight peak in one experiment. For Sources of variation. The concentration of relaxin in different placentomes showed consider¬ able variation (see Table 2 ). Whilst some of this was probably physiological it seemed likely that differences also arose during collection and processing. Two possible factors were investigated: (1) method of freezing, and, (2) length of storage. Individual placentomes were either frozen on solid C02 (n values for the two groups were 3-8 + 1-78 and 4-9 ± 2-59 ng/g, which were not significantly different.
To investigate losses during storage, a number of placentomes were collected from one ewe at 100 days' gestation, frozen on solid C02 and stored at -80°C. About 20 g tissue were removed from this stock on 6 occasions at intervals from 4 to 21 weeks after collection, extracted and run on a column of Sephadex G-50. The amount of RXN-IR detectable showed a steady reduction from 4-4 to 0-07 ng/g during this period, representing a loss of about 98% of the activity. Subsequently, samples were always extracted within 3 days of collection. Other tissues Intercotyledonary endometrium. Tissue was obtained from 2 ewes near term (> 125 days' ges¬ tation) and extracted as described above. The extract was applied to a column of Sephadex G-50 and each fraction was measured by RXN-RIA. In both cases the 3-peak pattern was seen (Fig. 6) Corpus luteum. In early experiments ovaries containing corpora lutea were obtained from preg¬ nant ewes, frozen on solid C02, stored at -20°C for between 1 week and 8 months, pooled for all stages of pregnancy and extracted in batches of 13-22 g (mean ovary weight = 1-2 g). The extract was applied to a column of Sephadex G-50 and the fractions measured by RXN-RIA. The peak pattern was very variable with activity detected in high, medium and low molecular weight ranges. The total immunoreactivity (for all molecular weights) was 1 05 + 0-66 ng/g (mean + s.e.m.,« = 7).
Discussion
This investigation provides evidence that relaxin-like material can be isolated from the placenta of the ewe. The majority of this material has a molecular weight of about 6000, characteristic of relaxin in other species, and it can be purified further by using ion exchange chromatography to give a peak which elutes in a position similar to that of pig relaxin. The immunological activity was confirmed using several antisera to pig relaxin obtained from 3 different sources, including one which had been purified by affinity chromatography using CM-a relaxin. Clear biological activity was found on a number of occasions in both crude extracts and Sephadex G-50 purified material using a uterine strip bioassay. Our inability to obtain uterine inhibition with the CM-cellulose purified extracts can almost certainly be attributed to a lack of sufficient material. It is likely that the inhibition of uterine contractions was caused by a relaxin-like peptide as the effect was similar to that obtained using pig and rat relaxins. The extraction and fractionation procedures should exclude other known myometrial inhibitors such as steroids, prostaglandins, catecholamines and histamine. A non-specific toxic effect is unlikely as the strips recovered their original level of activity following wash-out, and other fractions from the same extracts either had no effect or caused stimulation.
Earlier studies concerning the presence of relaxin in the ewe have been equivocal. Hall et al (1962) used a mouse interpubic ligament assay and found no convincing evidence of relaxin bio¬ activity in serum collected from ewes in the last 2 months of pregnancy and Renegar & Larkin (1985) could only detect immunoreactivity in 3 of 54 serum samples collected from the uterine vasculature of pregnant ewes. Immunoreactivity was measured in sheep plasma during the oestrous cycle (Chamley et al, 1975) , pregnancy (Bryant & Chamley, 1976a) and lactation (Bryant & Chamley, 1976b) . Impurities in the porcine relaxin standard used in this work (Bryant, 1972) may have contributed to the high plasma relaxin concentrations reported (e.g. 200 ng/ml during parturition). Alternatively, it is possible that impurities in the antigen and/or the direct assay of the plasma samples allowed for the measurement of higher molecular weight forms of relaxin which could be broken down during the extraction procedure used in the present paper. Renegar & Larkin (1985) have found low levels of relaxin-immunoreactivity in endometrium, placenta and ovaries of ewes at 45 and 140 days of gestation. Concentrations were similar in all tissues and at both times giving an overall concentration of 0-57 ± 013 ng pig relaxin equivalents per g tissue.
They found that immunoreactivity was present in most fractions after Sephadex G-50 purification with a peak in the range of Mr 12 000-16 000 but they were unable to demonstrate bioactivity. Renegar & Larkin (1985) used an acid-acetone extraction method whereas we used the method devised by Walsh & Niall (1980) (1980) from extracts of corpus luteum from late pregnant cows. This relaxin-like material from cows had an apparent molecular weight of about 1400 and was bioactive in the mouse uterine activity and interpubic ligament separation bioassays. Although it seems unlikely that a peptide of this size should retain both the bio-and immunoactivity of the 6000 molecular weight form of relaxin, the similarity in the results of these two studies on ruminants suggests that the subject merits further investigation. All this work indicates that relaxin can be produced in various forms and it remains a possibility that these might exhibit different biological activities.
The cells which synthesize relaxin in the ewe have still not been identified and the results of both this study and that of Renegar & Larkin (1985) suggest that activity is present in placentomes, endometrium and corpus luteum. A dual uterine and ovarian source has also been indicated in the human (O'Byrne et al, 1978; Bigazzi et al., 1982) . The much greater weight of placentomes compared with luteal tissue during gestation suggests that the placenta is likely to be the main source of sheep relaxin.
The role of relaxin in sheep is also speculative. Pig relaxin is a potent inhibitor of myometrial contractions in ovariectomized oestrogen-primed ewes , suggesting that the hormone could contribute in the ewe to maintaing uterine quiescence. Other possibilities are remodelling of the connective tissue framework of the uterus during pregnancy and distension of the cervix at parturition (for review, see Porter, 1979) . Some of these queries may be resolved by improved purification techniques or gene isolation leading to the production of sufficient sheep relaxin to develop homologous assay techniques.
